Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel disease

Inflammatory bowel disease (IBD) is refractory to treatment in one-half of patients.

Source: Digestive and Liver Disease - August 1, 2017 Category: Gastroenterology Authors: James O. Lindsay, Alessandro Armuzzi, Javier P. Gisbert, Bernd Bokemeyer, Laurent Peyrin-Biroulet, Geoffrey C. Nguyen, Michael Smyth, Haridarshan Patel Tags: Alimentary Tract Source Type: research